Home > Pressrelease > U.S. Clinical Nutrition Market size to exceed $19.7bn by 2028

U.S. Clinical Nutrition Market size to exceed $19.7bn by 2028

  • Published Date: March 11, 2022

U.S. Clinical Nutrition Market size is set to exceed USD 19.7 billion by 2028, according to a new research report by Global Market Insights Inc.

Surging incidence of premature births and birth rate is anticipated to drive the market growth. As per the report published by the Centers for Disease Control and Prevention (CDC), in 2020, around 10.1% of infants were born prematurely. The report also manifested that every 1 out of 10 infants were affected with premature birth in U.S. This rise in premature birth is due to multiple times of pregnancy, use of assisted reproductive methods, problems related with placenta, cervix or uterus, etc. Similarly, according to the National Vital Statistics System (NVSS), in 2020, over 360,520 new infants were born in U.S. The majority age of the females giving birth was between 30-35 years. It has been observed that the most prominent maternal age delivering premature infants was between 40-44 years. This may rise a severe health concern associated with low immunity in newborn that may cause various chronic diseases and deficiency of vitamin B12 in the newborn. Therefore, demand for clinical nutrition has augmented in the past few years as it facilitates precise and efficient nutrition modification in the body.

High junk food consumption leading to malnourishment is expected to stimulate the market statistics

The growing consumption of high junk food leading to malnutrition among people in U.S. is anticipated to drive the market expansion considerably throughout the forecast timeframe. Rising prevalence of malnourishment can cause a long-term effect on the body leading to several chronic as well as health related risk such as obesity, heart disease and diabetes, etc. Some of the major causes of malnourishment include insufficient intake of micronutrients, partial absorption of nutrition by the body, excessive alcohol consumption and mental health disorders.

Additionally, consumption of high junk food has been observed among the people in the U.S. and is a major concern for undernourishment among country’s citizens. According to an article published in 2020, stated that over 1% of children in U.S. suffers from chronic malnutrition. Due to the ongoing Covid-19 pandemic the awareness about clinical nutrition has been increased in the recent years. Various initiatives and campaigns are carried out by the U.S. government to create awareness regarding clinical nutrition products. Hence, the increasing prevalence of malnourishment coupled with consumption of high junk food is expected to stimulate the U.S. clinical nutrition market demand.

Surge in the use of enteral nutrition for undernourished patients is anticipated to spur the market share

Based on product, the U.S. clinical nutrition market is segmented as infant nutrition, enteral nutrition, and parenteral nutrition. The enteral nutrition segment exceeded USD 4,002 million in 2021. This is primarily attributable to the growing demand for enteral nutrition in undernourished patients suffering from various diseases such as kwashiorkor, marasmus, anemia, among others. The surge in adoption of enteral nutrition is owing to the presence of adequate amount of carbohydrates, fats, proteins, micronutrients, and fluid supplied through products such as standard enteral composition and disease specific composition.

Additionally, increasing prevalence of metabolic disorders and high spending on healthcare have propelled the demand for adoption of cost-efficient enteral nutrition in U.S. According to an article published in 2020, approximately over 40,000 people in U.S. are using enteral nutrition to meet their daily nutritional value that is not delivered through regular food intake.

Browse key industry insights spread across 80 pages with 52 market data tables & 15 figures & charts from the report, U.S. Clinical Nutrition Market Forecasts By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2022– 2028 in detail along with the table of contents:


Rising prevalence of chronic diseases in adults is expected to fuel the market trends

Based on consumer, the U.S. clinical nutrition market is segmented as pediatric and adult. The adult segment held a significant market share and was valued at over 4,799 million in 2021. The adult population in the U.S. is surging at a notable rate and has already met the youngster population level. For instance, according to a published article, over 46 million people in the country are aged more than 65 years and this number is further expected to reach over 90 million by 2050. The lack of nutritional intake in adult patients is leading to various chronic diseases. The growing adult population is proving conducive for the surging demand of clinical nutritional products in the country.

Various government initiatives have been carried out to increase the awareness and benefits of clinical nutrition among adults. In 2019, approximately 133 million adults between the age group of 25-40 years were suffering from chronic diseases due to malnourishment. Thus, owing to all the above-mentioned factors the increasing adult population is further anticipated to accelerate in the coming decades, thereby propelling the U.S. market revenue.

Several advantages offered by clinical nutrition in treatment of metabolic disorders is projected to expand the existing customer pool

Based on application, the U.S. clinical nutrition market is segmented into cancer, metabolic disorders, neurological diseases, gastrointestinal disorders, and others. The metabolic disorder segment is projected to reach over USD 6,377 million by 2028. The rising prevalence of metabolic disorders has paved the way for U.S. clinical nutrition market to witness a healthy growth in the upcoming years. Metabolic disorders often occur when the metabolic systems fails to absorb the necessary amount of essential nutrient in the body. Some of the most common metabolic disorders are Gaucher’s disease, hereditary hemochromatosis, maple syrup urine disease, etc. Clinical nutrition plays a vital role in the treatment of these metabolic disorders.

Increasing availability of clinical nutrition products in pharmacies & drug stores will spur market statistics

Based on distribution channel, the U.S. clinical nutrition market is segmented into retail stores, pharmacies & drug stores, online channels, and others. The pharmacies & drug stores segment was valued at USD 3,268 million in 2021. This advancement is attributed to the rising adoption of clinical nutrition products by people as they are easily available in pharmacies & drug stores. Several market players are emphasizing to introduce clinical nutrition products with high health benefits. Extensive research models are adopted by the market players to study and understand different causes of chronic diseases due to malnourishment and advantages offered by clinical nutrition for their treatment.

Increasing number of pharmacies and drug stores have elevated the distribution of clinical nutrition products to the remote areas of the U.S. According to a report, there are over 88,000 pharmacies & drug stores available in the U.S. that provide clinical nutritional products to citizens. Owing to numerous clinical advantages offered by the clinical nutrition products to patients across the age category, the segment is set to fuel the market growth in the coming years.

Key players are adopting several business strategies to capture significant market share

Some of the major companies operating in the U.S. clinical nutrition market are Nestle Health Science, Fresenius Kabi, Abbott Laboratories, Danone, B Braun Melsungen AG, Baxter International Inc., Mead Johnson (Reckitt Benckiser), and Perrigo. These players are engaged in strategic collaborations, partnerships and agreements to gain a competitive advantage over their competitors. For instance, in August 2021, Esperer Nutrition launched a range of consumer nutraceuticals for bone-joint health, immunity, urinary tract health, sleep apnea, and pre-diabetic care. This helped the company to gain a wide customer base and enhance their product portfolio thereby increasing their business revenue.

Authors: Sumant Ugalmugle, Rupali Swain